Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4082949
Max Phase: Preclinical
Molecular Formula: C12H17O9P
Molecular Weight: 336.23
Molecule Type: Small molecule
Associated Items:
ID: ALA4082949
Max Phase: Preclinical
Molecular Formula: C12H17O9P
Molecular Weight: 336.23
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=P(O)(O)OC[C@H]1O[C@@H](Oc2ccccc2)[C@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C12H17O9P/c13-9-8(6-19-22(16,17)18)21-12(11(15)10(9)14)20-7-4-2-1-3-5-7/h1-5,8-15H,6H2,(H2,16,17,18)/t8-,9-,10+,11-,12-/m1/s1
Standard InChI Key: YOENDVQTCKDPMO-RMPHRYRLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 336.23 | Molecular Weight (Monoisotopic): 336.0610 | AlogP: -1.02 | #Rotatable Bonds: 5 |
Polar Surface Area: 145.91 | Molecular Species: ACID | HBA: 7 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.22 | CX Basic pKa: | CX LogP: -0.72 | CX LogD: -4.25 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.43 | Np Likeness Score: 1.65 |
1. Liu C, Dunaway-Mariano D, Mariano PS.. (2017) Rational design of reversible inhibitors for trehalose 6-phosphate phosphatases., 128 [PMID:28192710] [10.1016/j.ejmech.2017.02.001] |
Source(1):